CME Group Inc (CME) carries a ŷRobot AI score of 53 out of 100. The model's fair value estimate is $264.20, 0.4% above the last close of $263.24. The chart signal reads Hold.
| Metric | CME |
|---|---|
| AI score | 53 / 100 |
| Chart signal | Hold |
| Fair value estimate | $264.20 |
| Upside to fair value | 0.4% |
| Previous close | $263.24 |
| P/E | 23.82 |
| Price / sales | 15.19 |
| Market cap | $94.66B |
| EPS | 12.00 |
| Revenue growth | 8.7% |
| 1-year price change | 9.7% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Financial Services stocks: JPMorgan Chase & Co, Visa Inc. Class A, Mastercard Inc, Bank of America Corp, HSBC Holdings PLC ADR, Morgan Stanley.
As of Sep 29, 2026, ŷRobot's fair-value model estimates CME Group Inc (CME) at $264.20 against a last close of $263.24, implying 0.4% upside to the model's estimate.
The chart-signal model classifies CME as Neutral as of Sep 29, 2026, with a signal score of 0.05 on a -1 to 1 scale.
CME scores 53 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Sep 29, 2026.
CME trades at 23.8 times earnings and 15.2 times sales as of Sep 29, 2026.
ŷRobot's seasonal forecast curve for CME reads +1.1% at 30 days, +6.0% at 90 days, and +9.7% at one year as of Sep 29, 2026. Seasonal tendencies are historical patterns, not predictions.
CME Group Inc's revenue growth is +8.7% and free-cash-flow growth is -33.8% on the latest reported figures.
CME chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.